BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31178335)

  • 1. Cerebrospinal fluid cytokines in multiple system atrophy: A cross-sectional Catalan MSA registry study.
    Compta Y; Dias SP; Giraldo DM; Pérez-Soriano A; Muñoz E; Saura J; Fernández M; Bravo P; Cámara A; Pulido-Salgado M; Painous C; Ríos J; Martí MJ;
    Parkinsonism Relat Disord; 2019 Aug; 65():3-12. PubMed ID: 31178335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early strong intrathecal inflammation in cerebellar type multiple system atrophy by cerebrospinal fluid cytokine/chemokine profiles: a case control study.
    Yamasaki R; Yamaguchi H; Matsushita T; Fujii T; Hiwatashi A; Kira JI
    J Neuroinflammation; 2017 Apr; 14(1):89. PubMed ID: 28438224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.
    Compta Y; Giraldo DM; Muñoz E; Antonelli F; Fernández M; Bravo P; Soto M; Cámara A; Torres F; Martí MJ;
    Parkinsonism Relat Disord; 2018 Jan; 46():16-23. PubMed ID: 29107645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid pro-inflammatory cytokines differentiate parkinsonian syndromes.
    Starhof C; Winge K; Heegaard NHH; Skogstrand K; Friis S; Hejl A
    J Neuroinflammation; 2018 Nov; 15(1):305. PubMed ID: 30390673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine profiling in the prefrontal cortex of Parkinson's Disease and Multiple System Atrophy patients.
    Rydbirk R; Elfving B; Andersen MD; Langbøl MA; Folke J; Winge K; Pakkenberg B; Brudek T; Aznar S
    Neurobiol Dis; 2017 Oct; 106():269-278. PubMed ID: 28732710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM; Kuiperij HB; Bruinsma IB; van Rumund A; Aerts MB; Esselink RAJ; Bloem BR; Verbeek MM
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid and plasma distribution of anti-α-synuclein IgMs and IgGs in multiple system atrophy and Parkinson's disease.
    Folke J; Rydbirk R; Løkkegaard A; Hejl AM; Winge K; Starhof C; Salvesen L; Pedersen LØ; Aznar S; Pakkenberg B; Brudek T
    Parkinsonism Relat Disord; 2021 Jun; 87():98-104. PubMed ID: 34020303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.
    Santaella A; Kuiperij HB; van Rumund A; Esselink RAJ; van Gool AJ; Bloem BR; Verbeek MM
    BMC Neurol; 2020 Jan; 20(1):26. PubMed ID: 31952511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid myelin basic protein is elevated in multiple system atrophy.
    Santaella A; Kuiperij HB; van Rumund A; Esselink RAJ; Bloem BR; Verbeek MM
    Parkinsonism Relat Disord; 2020 Jul; 76():80-84. PubMed ID: 32576494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls.
    Herbert MK; Eeftens JM; Aerts MB; Esselink RA; Bloem BR; Kuiperij HB; Verbeek MM
    Parkinsonism Relat Disord; 2014 Jan; 20(1):112-5. PubMed ID: 24075122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders.
    Hall S; Öhrfelt A; Constantinescu R; Andreasson U; Surova Y; Bostrom F; Nilsson C; Håkan W; Decraemer H; Någga K; Minthon L; Londos E; Vanmechelen E; Holmberg B; Zetterberg H; Blennow K; Hansson O
    Arch Neurol; 2012 Nov; 69(11):1445-52. PubMed ID: 22925882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy.
    Kwon DH; Hwang JS; Kim SG; Jang YE; Shin TH; Lee G
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlations of cerebrospinal fluid biomarkers including neuron-glia 2 and neurofilament light chain in patients with multiple system atrophy.
    Tokutake T; Kasuga K; Tsukie T; Ishiguro T; Shimohata T; Onodera O; Ikeuchi T
    Parkinsonism Relat Disord; 2022 Sep; 102():30-35. PubMed ID: 35933820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Lymphocyte-Associated Cytokine Concentrations Change More Rapidly over Time in Multiple System Atrophy Compared to Parkinson Disease.
    Csencsits-Smith K; Suescun J; Li K; Luo S; Bick DL; Schiess M
    Neuroimmunomodulation; 2016; 23(5-6):301-308. PubMed ID: 28395279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers β-amyloid, tau proteins and a-synuclein in the differential diagnosis of Parkinson-plus syndromes.
    Constantinides VC; Paraskevas GP; Emmanouilidou E; Petropoulou O; Bougea A; Vekrellis K; Evdokimidis I; Stamboulis E; Kapaki E
    J Neurol Sci; 2017 Nov; 382():91-95. PubMed ID: 29111028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
    Front Immunol; 2018; 9():2122. PubMed ID: 30283455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
    Hall S; Janelidze S; Surova Y; Widner H; Zetterberg H; Hansson O
    Sci Rep; 2018 Sep; 8(1):13276. PubMed ID: 30185816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.